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Background. Natural killer T (NKT) cells are a subset of T cells that help potentiate and regulate immune responses. Although
human NKT cell subsets with distinct effector functions have been identified, it is unclear whether the effector functions of
these subsets are imprinted during development or can be selectively reprogrammed in the periphery. Results. We found that
neonatal NKT cells are predominantly CD4+ and express higher levels of CCR7 and CD62L and lower levels of CD94 and CD161
than adult CD4+ or CD42 NKT cell subsets. Accordingly, neonatal NKT cells were more flexible than adult CD4+ NKT cells in
their capacity to acquire Th1- or Th2-like functions upon either cytokine-mediated polarization or ectopic expression of the Th1
or Th2 transcription factors T-bet and GATA-3, respectively. Consistent with their more differentiated phenotype, CD4- NKT
cells were predominantly resistant to functional reprogramming and displayed higher cytotoxic function. In contrast to
conventional T cells, neither the expression of CXCR3 nor the cytotoxic capacity of neonatal NKT cells could be reprogrammed.
Conclusions and Significance. Together, these results suggest that neonatal CD4+, adult CD4+, and adult CD42 NKT may
represent unique states of maturation and that some functions of human NKT cells may be developmentally imprinted, while
others are acquired similar to conventional T cell subsets during peripheral maturation and differentiation. Given the potent
immuno-regulatory functions of NKT cells, these findings have important implications for the development of novel NKT cell-
based therapeutics and vaccines.
Citation: Eger KA, Sundrud MS, Motsinger AA, Tseng M, Van Kaer L, et al (2006) Human Natural Killer T Cells Are Heterogeneous in Their Capacity to
Reprogram Their Effector Functions. PLoS ONE 1(1): e50. doi:10.1371/journal.pone.0000050
INTRODUCTION
NKT cells play important and multifaceted roles in immune
regulation, tumor rejection and resistance to a variety of viral,
bacterial, and parasitic pathogens through their rapid secretion of
immunoregulatory cytokines and potent cytotoxicity [1–4]. NKT
cells are characterized by a highly conserved T cell receptor (TCR)
in both mice and humans [5–9], with human NKT cells most
reliably identified by the expression of their invariant TCR,
consisting of a Va24-Ja18 chain preferentially paired with a Vb11
chain [10–12]. NKT cells are present at low and highly variable
frequencies in human blood (0.01%–1%) but are present at higher
numbers in the liver [13–15].
In contrast to conventional T cells, NKT cells recognize
glycolipid antigens presented by the non-polymorphic MHC class-
I like molecule CD1d [5,16–18]. The marine sponge derived
glycosphingolipid a-galactosylceramide (a-GalCer) was the first
synthetic NKT ligand identified that specifically stimulated NKT
cells in the context of CD1d [19]. More recently, NKT cells have
been shown to recognize and respond to an endogenous lysosomal
glycosphingolipid, isoglobotrihexosylceramide [20]. Several bac-
terial derived glycolipids have also been recently shown to activate
NKT cells [9,21–25].
NKT cells can be phenotypically subdivided into CD4+ and
CD42 subsets. A portion of both human and monkey NKT cells
also express CD8 [26–31]. While human adult NKT cells are
comprised of both CD4+ and CD42 subsets, neonatal NKT cells
are almost exclusively CD4+ [32–34]. Furthermore, CD4+ NKT
cells but not CD42 NKT cells have been shown to develop in the
human fetal thymus [32,34]. It remains unclear whether CD42
NKT cells develop from precursor CD4+ NKT cells or as
a separate lineage.
Upon activation, NKT cells rapidly secrete large amounts of
cytokines, including interferon gamma (IFN-c) and IL-4. While
some functional differences between human CD4+ and CD42
NKT cells have been described [27,28,35], it is presently unclear
whether NKT cells are solely comprised of subsets that are
hardwired to secrete specific cytokine patterns or if some of these
subsets can modify their effector functions during peripheral
immune activation, analogous to conventional T cells. In contrast
to murine NKT cells, which were reported to be resistant to
cytokine polarization in vivo [36], upon activation with either
environmentally instructed dendritic cells (DCs) or DC1 and DC2
antigen presenting cells (APCs), human NKT cells have been
shown to undergo polarization into cells with Th1- or Th2-like
cytokine production profiles, termed NKT1 and NKT2 cells
[37,38]. A strong correlation between CD4 expression and the
capacity to produce Th2 cytokines has also been reported
[27,28,35]. Examination of the expression patterns of chemokine
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leukocyte trafficking, have revealed further differences between
CD4+ and CD42 NKT cells [35].
In the current study, we demonstrate that neonatal CD4+
(nCD4+), adult CD4+ (aCD4+) and adult CD42 (aCD42) NKT
cells are phenotypically distinct in their expression of effector/
memory T cell markers and NK cell markers. Consistent with
their more naı ¨ve phenotype, we also demonstrate that some, but
not all, of the effector functions of human nCD4+ NKT cells can
be easily modified through either polarizing cytokines or ectopic
expression of the master Th1 and Th2 transcription factors (TFs)
T-bet and GATA-3, respectively. By comparison, aCD4+ NKT
cells were less permissive, whereas aCD42 NKT cells were largely
refractory to these polarizing signals. These findings have
implications for harnessing and reprogramming the effector
functions of human NKT cells in vivo for novel therapeutic and
vaccine approaches.
RESULTS
Phenotypic characterization of humanNKT cell subsets
Human NKT cells can be subdivided into CD4+ and CD42
subsets, which display functionally distinct cytokine secretion
profiles [27,28,35]. We further characterized the expression
profiles of a panel of cell surface markers on resting nCD4+,
aCD4+ and aCD42 NKT cells. Neonatal NKT cells were
predominantly (.90%) CD4+, whereas adult blood NKT cells
were either CD4+ or CD42, with variable levels of CD8
expression (Figure 1A), which is consistent with previous reports
[32,33]. The chemokine receptor CCR7 and the lymph node
homing receptor CD62L, which are specifically expressed on
naı ¨ve and central memory T cells [39], were expressed highly on
nCD4+, moderately on aCD4+, and relatively lower on aCD42
NKT cells (Figures 1B and 1C). In contrast, expression of the NK
lineage receptors CD94 and CD161 were mostly absent on
nCD4+ T cells but detected at moderate and high levels on
aCD4+ and aCD42 NKT cells, respectively (Figures 1B and 1C).
Expression of the co-stimulatory molecule CD28 was high on all
subsets, but statistically higher on nCD4+ NKT cells compared to
either adult NKT cell subsets (Figures 1B and 1C). Because we
observed heterogeneous expression of the above markers on
aCD4+ NKT cells from different donors, we next determined
whether these markers were expressed coordinately on cells from
the same donor, such that donors with high levels of CCR7 also
expressed high levels of CD62L and low levels of CD161, and
vice-versa. Because CD161 and CD62L are inversely expressed
Figure 1. Identification of NKT cell subsets in neonatal and adult blood PBMC. (A) NKT cells in either neonatal or adult PBMC were identified by
staining for the invariant TCR using antibodies against Va24 (FITC) and Vb11 (unlabelled followed by goat anti-mouse APC). Double positive cells
were identified as NKT cells and gated on for further analysis to determine CD4 (PE) and CD8 (biotin followed by strepavidin-PerCP-Cy5.5) expression.
(B) NKT cell subsets were identified by staining for Va24, Vb11, and CD4 as in 1A and then gated on for further analysis. Expression of the indicated
cell surface marker on these subsets was then determined. Combinations of the following antibodies were used, depending on the particular stain:
Va24 (FITC or unlabelled), Vb11 (unlabelled or PE), CD4 (PE, biotin, or unlabelled), CCR7 (unlabelled), CD62L (PE), CD94 (unlabelled), CD161 (FITC),
CD28 (biotin), goat anti-mouse (APC), and strepavidin (PerCP-Cy5.5). One representative donor is shown. (C) Summary of NKT cell phenotype data for
all neonatal and adult donors. P values are indicated. For comparison of nCD4+ to either aCD4+ or aCD42 subsets, P values were generated using the
Wilcoxon rank sum test. For comparison of aCD4+ to aCD42 subsets, P values were generated using the Wilcoxon signed rank test. (D) For CD4+ NKT
cells of adult donors represented in 1C, the ratio of CD161 (% expression) to CD62L (% expression) was generated and compared to CCR7 expression
using linear regression with a resulting equation of y=219.277X+86.676 and p=0.008.
doi:10.1371/journal.pone.0000050.g001
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a striking negative correlation (20.7765) between CCR7 expres-
sion and the ratio of CD161 and CD62L. The slope of the
associated regression line was statistically significant with a p
value=0.008 (Figure 1D). These results suggest that human
nCD4+, aCD4+ and aCD42 NKT cells may represent different
stages of maturation and that there is wide disparity in the
maturation state of the aCD4+ NKT cell pool, which can be
phenotypically subdivided into CCR7
highCD62L
highCD161
low
and CCR7
lowCD62L
lowCD161
high populations.
Ex vivo cytokine polarization of nCD4+, aCD4+ and
aCD42 NKT cell subsets
Conventional CD4+ T helper (Th) cells regulate adaptive immune
responses by differentiating into Th1 or Th2 effector subsets,
which produce either IFN-c or IL-4, respectively [40–42].
Although many factors contribute to the polarization of naı ¨ve
Th cell effector functions, cytokine signals during activation are
critical in this differentiation process. Specifically, IFN-c and IL-12
are instrumental in directing Th1 differentiation, whereas IL-4
promotes Th2 differentiation [40–42]. As naive Th cells
differentiate from naı ¨ve to effector/memory subsets, heritable
chromatin modifications at cytokine gene loci imprint an effector
program which results in Th cells that are less capable of
reprogramming their effector functions [43,44]. Therefore, we
investigated the extent to which NKT cell subsets that exhibit
distinct memory phenotypes could acquire Th1 or Th2-like
effector functions when activated in the presence of polarizing
cytokine signals.
Purified human neonatal or adult NKT cells were activated by
DCs pulsed with a-GalCer in the presence or absence of
conventional Th1- (IL-12, neutralizing IL-4 antibody) or Th2-
(IL-4, neutralizing IL-12 and IFN-c antibodies) polarizing
conditions, here termed NKT1 and NKT2 respectively. Following
activation, NKT cells were expanded for approximately 2.5 weeks
and their effector functions were determined. All NKT cell subsets
activated with DCs alone (NKT0) expressed high levels of IFN-c;
compared to adult subsets, NKT0 nCD4+ NKT cells also
produced relatively higher levels of IL-4 (Figure 2). When neonatal
CD4+ NKT cells were activated under NKT1 conditions these
cells displayed increased levels of IFN-c, however expression of IL-
4 was not greatly downregulated as compared to NKT0 cells
(Figure 2). Under Th2-like polarization signals, nCD4+ NKT cells
were easily programmed towards a NKT2 phenotype, as defined
by secretion of high levels of IL-4 and low levels of IFN-c
(Figure 2), similar to conventional naı ¨ve CD4+ T cells polarized to
Th2 cells under the same conditions (Figure S1). In contrast,
aCD42 NKT cells, and to a lesser extent aCD4+ NKT cells, were
more resistant to NKT2 polarization (Figure 2).
Certain chemokine receptors such as CXCR3 and CCR4 are
preferentially expressed on Th1 or Th2 cells, respectively [44,45].
To further examine the extent of NKT cell polarization, we
determined the expression levels of these chemokine receptors on
cytokine-polarized NKT cell lines. NKT0 nCD4+ NKT cells
expressed increased levels of the Th2-associated receptor CCR4
compared to either adult subset (Figure 3A), which is consistent
with their higher levels of IL-4 expression (Figure 2). CCR4
expression was strongly induced on nCD4+ NKT cells under
NKT2 polarizing conditions, but only moderately so on aCD4+
and even less so on aCD42 NKT cells (Figure 3A). Expression of
Th1-specific CXCR3 was highly expressed on all NKT cell subsets
and, in stark contrast to conventional Th cells [44], was not
substantially modulated by Th2-like cytokine polarization
(Figure 3B). Taken together, these results suggest that nCD4+,
and to a lesser extent aCD4+ NKT cells, have an enhanced
capacity to modify their effector functions as compared with their
CD42 counterparts. However, in contrast to conventional T cells,
NKT cells also display some pre-programmed characteristics,
which could not be modulated by cytokine polarizing signals.
Reprogramming NKT cell subset effector functions
by ectopic expression of the transcription factors
GATA-3 and T-bet
In conventional Th cells, Th1 and Th2 differentiation are directed
by the master transcription factors (TFs) T-bet and GATA-3,
respectively [46–48]. Whereas T-bet or GATA-3 are sufficient to
program Th1 or Th2 effector function when ectopically expressed
in conventional naı ¨ve Th cells, these same TFs are insufficient to
reprogram the established effector functions of memory Th cell
subsets [44]. Therefore, we asked whether bypassing cytokine
polarization signals by ectopically expressing T-bet or GATA-3
could overcome the resistance of adult NKT cells to effector
function reprogramming. Accordingly, NKT cells were purified as
before, activated using DCs pulsed with a2GalCer and simulta-
neously transduced with a lentiviral vector expressing either T-bet
or GATA-3, in conjunction with a reporter cell surface marker,
murine CD24 (mCD24). An empty vector expressing mCD24
alone was used as a negative control. Transduced NKT cells were
then expanded and assayed for cytokine production and
chemokine receptor expression as before, using mCD24 as
Figure 2. Cytokine polarization of NKT cell subsets. Neonatal or adult
NKT cells were purified and activated under conventional Th0 (medium
alone; NKT0), Th1 (NKT1), or Th2 (NKT2) polarizing conditions as
described in the methods and expanded in IL-2-containing media.
These cells were re-stimulated for 6–8 hours using DCs pulsed with a-
GalCer (100 ng/ml), or alternatively, anti-CD3 and anti-CD28, in the
presence of GolgiStop (BD) and were then intracellularly stained with
antibodies against IL-4 (PE) and IFN-c (APC). NKT cells were also co-
stained with anti-Vb11 (FITC) to exclude contaminating non-NKT cells.
For adult NKT cells, CD4 expression was also assessed by cell surface
staining (CD4-biotin followed by strepavidin-PerCP-Cy5.5) to differen-
tiate CD4+ from CD42 NKT cells. One representative donor out of 5 is
shown.
doi:10.1371/journal.pone.0000050.g002
Reprogramming Human NKT Cells
PLoS ONE | www.plosone.org 3 December 2006 | Issue 1 | e50a marker for transduction. Similar to cytokine polarization, T-bet
or GATA-3 expression in nCD4+ NKT cells was sufficient to drive
NKT1 or NKT2 polarization, respectively (Figures 4A and 4C).
As with the cytokine polarization experiments, ectopic expression
of either of these TFs did not modulate CXCR3 expression on
nCD4+ cells (Figure 4C). These results suggests that T-bet or
GATA-3 can partially function to program the effector function of
nCD4+ NKT cells. Ectopic expression of these TFs in either
aCD4+ or aCD42 NKT cell subsets was unable to overcome the
partial resistance of these subsets to effector function reprogram-
ming by cytokine signals (Figures 4B and 4D). Taken together,
these results suggest that, similar to conventional effector/memory
CD4+ Th subsets [44], bypassing cytokine receptor signaling does
not notably overcome the resistance of aCD42 NKT cells to
effector function reprogramming.
Differential cytotoxic function of human NKT cell
subsets
One of the characteristics of NKT cells is their cytotoxic function
[49]. We therefore asked whether NKT cell subsets differed in
their cytotoxic potential and whether this activity could be
regulated by cytokine polarization. For these experiments, we
developed a cytotoxicity assay using a murine fibroblast line (NIH
3T3 cells) which endogenously expresses CD1d and can present a-
GalCer to activate human NKT cells in a dose-dependent fashion,
as measured by up-regulation of the IL-2 receptor a chain, CD25
(Figure 5A). Further, upon TCR stimulation, NKT cells can kill
target 3T3 cells, also in an a-GalCer dose-dependent fashion
(Figure 5B). Using this assay, we tested the cytotoxic potential of in
vitro generated nCD4+, aCD4+ and aCD42 NKT cell lines. We
found that aCD42 NKT cells had higher cytotoxic activity against
a-GalCer presenting target 3T3 cells compared to either nCD4+
or aCD4+ NKT cells at a variety of effector to target ratios
(Figure 5C).
Because conventional Th1 CD4+ Th cell lines can exhibit
higher cytotoxicity relative to Th2 cells upon activation (Figure S2)
[50], we next asked whether NKT1 and NKT2 cells displayed
differences in their cytotoxic effector functions. For this experi-
ment we used nCD4+ NKT cells, since these could be much more
readily differentiated into NKT1 or NKT2 type cells (Figures 2
and 3A). In contrast to conventional CD4+ Th1 and Th2 subsets
activated with SEB and tested under these conditions (Figure S2),
nCD4+ NKT1 and NKT2 cells were similar in their cytotoxic
capacity (Figure 5D). These results suggest that, unlike cytokine
production and similar to CXCR3 expression, the cytotoxic
function of NKT cells appears to be developmentally imprinted.
DISCUSSION
Here, we have demonstrated that NKT cells from neonates are
phenotypically and functionally distinct from adult NKT cell
subsets. In comparison to aCD4+ NKT cells, nCD4+ NKT cells
exhibit: 1) higher expression of the differentiation markers CCR7
and CD62L, 2) lower expression of the NK cell markers CD161
and CD94, and 3) are more amenable to effector function
reprogramming. We also found wide heterogeneity within the
aCD4+ NKT cell subset for expression of memory markers. These
findings suggest that the pool of CD4+ NKT cells in adult
peripheral blood represents a more heterogeneous mixture of cells
with respect to their phenotype and stage of maturation. This
premise would predict that adult NKT cells are not recent thymic
emigrants, but have undergone some form of peripheral
maturation. Several lines of evidence are consistent with our
hypothesis. In one study, Va24+CD4+ NKT cell progenitors were
observed to be present in the early fetal thymus but rare in the
postnatal thymus, again suggesting the possibility that adult CD4+
NKT cells are likely to be peripherally expanded cells rather than
recent thymic emigrants [34]; other studies also reported low levels
of NKT cells in the postnatal thymus [32,33]. Analysis of T cell
receptor excision circles in NKT cells suggested that aCD4+ NKT
Figure 3. Chemokine receptor expression on polarized NKT cell
subsets. One representative neonatal or adult sample of 5 is shown for
each. (A) CCR4 expression on polarized NKT cell lines was assayed by
staining with anti-CCR4 (unlabelled followed by goat anti-mouse APC)
and anti-CD4 (PE) to differentiate between adult CD4+ and CD42 NKT
cells and anti-Vb11 (FITC) to exclude contaminating non-NKT cells.
Isotype control is depicted in light gray. (B) CXCR3 (unlabelled followed
by goat anti-mouse APC) expression on polarized NKT cell subsets were
assayed as in 3A.
doi:10.1371/journal.pone.0000050.g003
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and peripheral expansion [32]. Despite expression of the memory
marker CD45RO, resting neonatal NKT cells were also reported
to be functionally immature as defined by their inability to
produce IL-4 or IFN-c upon primary activation and only acquired
their effector functions after cell division, implying that in vivo
activation and peripheral expansion are necessary to attain
functional maturation [32,51].
Several lines of evidence presented here also clearly suggest that
aCD42 NKT cells are more differentiated compared to CD4+
subsets: 1) aCD42 NKT cells displayed lower expression levels of
CD62L and CCR7 and increased expression levels of CD94 and
CD161, 2) aCD42 NKT cells were predominantly resistant to
reprogramming either via polarizing cytokine signals or ectopic
expression of T-bet or GATA-3, and 3) aCD42 NKT cells also
displayed greater cytotoxic activity compared to either nCD4+ or
aCD4+ NKT cells. Based on these findings, we hypothesize that
CD4 is a differentiation marker for human NKT cells, such that
CD42 NKT cells may possibly represent a product of precursor
CD4+ NKT cells which have undergone peripheral maturation.
This hypothesis is also supported by the findings that aCD4+
NKT cells contain a higher level of T cell receptor excision circles
than aCD42 NKT cells [32] and that CD42 NKT cells are
absent in neonates and only begin to accumulate after about
6 months of age [32–34].
Conventional Th cells progressively lose the capacity to modify
their effector functions as they differentiate from naı ¨ve cells to
central and effector memory cells [43,44]. Therefore the flexibility
of nCD4+, aCD4+ and aCD42 NKT cell subsets to reprogram
effector functions could be a reflection of their differentiation state,
as defined by the expression of memory T cell markers and NK
cell lineage receptors, as well as their cytotoxic capacity. We
speculate that the phenotypic and functional profiles of neonatal
CD4+ and adult CD42 NKT cells are analogous to conventional
naı ¨ve and memory Th cell profiles [39,43,44]. However, in
contrast to conventional Th cells, several NKT cell effector
functions (such as cytotoxity and CXCR3 expression), which can
be modulated in conventional T cells, were not responsive to
polarizing cytokine signals or forced expression of TFs. We also
observed that nCD4+ cells had higher expression levels of IL-4
under NKT1 polarizing conditions compared to conventional Th1
cells, which rapidly silence the IL-4 locus. However, because the
aCD42 subset has reduced expression of IL-4 and CCR4 in non-
polarizing conditions [27,28,35] (Figures 2 and 3A), as well as
increased cytotoxicity (Figure 5C), it is conceivable that these
functions are modified in vivo as NKT cells are activated by
antigens and/or cytokines such as IL-12, which has been
speculated to contribute to the peripheral maturation of NKT
cells [52]. However, the importance of factors such as co-
stimulation, cytokine signals present at the time of activation,
Figure 4. Functional profile of NKT cell subsets ectopically expressing T-bet or GATA-3. NKT cells were activated under non-polarizing conditions
as in Figure 2, transduced at the time of activation with either the control lentiviral vector or vectors expressing T-bet or GATA3, and expanded in IL-
2-containing media. One representative donor out of 3 is shown for each. (A) Intracellular stain of nCD4+ NKT cells was performed as in Figure 2 and
cells were co-stained with anti-mCD24 (FITC) to identify transduced cells. (B) Intracellular cytokine stains of aCD4+ or aCD42 NKT cells were
performed as in 4A. CD4 expression was determined by co-staining with anti-CD4 (biotin followed with strepavidin PerCP-Cy 5.5). (C) CCR4 or CXCR3
expression on T-bet- or GATA-3-transduced nNKT cells was assayed as in Figures 3A and 3B, and cells were co-stained with anti-mCD24 (FITC) as
a marker for transduction. (D) CCR4 expression of T-bet or GATA-3-transduced aCD4+ or aCD42 NKT cell was examined as in 4C, and cells were
stained with anti-CD4 (PE) to differentiate between CD4+ and CD42 NKT cells.
doi:10.1371/journal.pone.0000050.g004
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whether endogenous or foreign, in the differentiation and
maturation process of NKT cells remains to be elucidated.
The functional differences between conventional Th and NKT
cells described in these studies could potentially result from
distinct, lineage-specific transcriptional regulatory mechanisms, or
alternatively, may reflect unique developmentally imprinted
genetic programs. As such, because the positive selection of
NKT cells is mediated by double-positive thymocytes rather than
cortical epithelial cells [53], it is possible that the unique
developmental program of NKT cells may result in qualitatively
different signals that impact subsequent functional programs.
Indeed, NKT cell development differs from conventional T cells in
the required expression of several transcription and signaling
molecules, including T-bet, NF-kB and PKC-h[54–58], thus
suggesting unique developmental signals.
While we have shown here that certain functions of NKT cells
are likely to be developmentally imprinted, others can be readily
modulated, at least in the CD4+ NKT cell subset. It is not clear
how NKT cells would acquire different functional profiles in vivo.
Although murine NKT cells were reported to be resistant to
cytokine polarization in vivo [36], direct ex-vivo cytokine
mediated polarization was not assessed and in various other
experimental systems evidence suggests that the nature of the
antigen [17,59–62], the type of antigen presenting cell [37,38,63],
and the presence or absence of co-stimulatory signals [64,65]
could all play a role in modulating the functional and phenotypic
profiles of NKT cells. For example, distinct structural analogs of
a2GalCer can elicit different cytokine secretion profiles by NKT
cells [17,59–62]. While both human NKT cell subsets produce
IFN-c, CD4+ NKT cells produce higher levels of Th2 cytokines
than CD42 NKT cells, suggesting that NKT cell effector function
may also be regulated through the selective recruitment and
activation of these subsets [27,28,35]. Furthermore, it was recently
demonstrated that murine NKT cells from different organs may
mediate distinct functions [66], raising the possibility that naı ¨ve-
like NKT cell subsets may be recruited to different organs where
they can undergo divergent effector function programming into
distinct effector subsets. Indeed, similar mechanisms appear to be
in place for conventional Th cells, whereby specialized, tissue-
specific APCs can fine-tune T cell effector function [67].
Dysregulation of NKT cell function has been linked to a variety
of immune deficiencies and pathologies. In comparison to normal
healthy donors, which possess very low levels of NKT cells in the
Figure 5. Cytotoxic capability of NKT cell subsets. Experiments were performed in triplicate per donor; standard deviation is depicted. For A, B, C,
and D, one representative donor out of three independent experiments is shown. (A) NKT cells were added at an Effector:Target (NKT cell: 3T3 cell)
ratio of 1:1 to adherent 3T3 cells in the presence of different a-GalCer concentrations. After 18–20 hours, NKT cells were collected and stained with
anti-CD25 (unlabelled followed by goat anti-mouse APC) to determine activation. (B) As in A, NKT cells at an NKT:3T3 of 1:1 were activated in the
presence of varying concentrations of a-GalCer. After 18–20 hours, cells were collected by trypsinization to remove any 3T3 cells that were still
adherent and target 3T3 cells were stained with propidium iodide to determine their viability. (C) a-GalCer was added at a concentration of 100 ng/ml
to adherent 3T3 cells. NKT cell subsets were then added at different NKT:3T3 ratios. Viability of 3T3 cells after an 18–20 hour incubation period was
determined as in 5B. (D) Polarized nCD4+ NKT cells were generated as in Figure 2. The cytotoxic capacity of these NKT0, NKT1, and NKT2 lines was
assayed as in Figure 5C. One NKT:3T3 ratio for each donor is shown.
doi:10.1371/journal.pone.0000050.g005
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bronchial asthma patients were NKT cells, with greater than 90%
representing CD4+ NKT cells that expressed IL-4 but little IFN-c
[68]. Other examples of the role of NKT cells in autoimmunity,
tumor biology and infection have also been reviewed [4,9]. Our
findings highlight the possibility that therapeutic manipulation of
NKT cells to improve immune responses against autoimmune or
infectious diseases may be most optimally achieved by targeting
specific subsets rather than the entire NKT cell pool. While CD4+
NKT cells are amenable to reprogramming, CD42 NKT cells are
functionally static. Conceivably, some autoimmune conditions
may be circumvented by activation conditions that preferentially
target CD4+ NKT cells and favor the development of strong Th2
responses. Also, the potent anti-tumor or anti-viral activity of
NKT cells may be most beneficial under activation conditions that
preferentially favor the development of either NKT1 or CD42
NKT cells, which can potently mediate the downstream activation
of NK cells and CD8+ cytotoxic T lymphocytes, further
amplifying anti-tumor or viral activity. Of note and in contrast
to conventional T cells, we were unable to modulate the direct
cytotoxic activity of NKT cells. As a better understanding of the
mechanisms that regulate NKT cell function is achieved and as
novel ligands that can specifically modulate these functions are
generated, it may be possible to specifically boost these types of
responses in vivo.
In conclusion, our results reveal both imprinted and highly
flexible differentiation and effector programs of neonatal NKT
cells, whose flexibility progressively diminish in adult NKT cells as
they acquire a more differentiated phenotype. These findings
suggest that CD4+ and CD42 NKT cells may represent unique
differentiation states. While we cannot exclude the possibility that
CD42 NKT cells may develop as a separate lineage, our studies in
conjunction with previous reports [32,34], support a linear model
of human NKT cell differentiation. Because NKT cells serve as an
important link between the innate and adaptive immune system,
our results have important implications for the design of novel
therapeutic interventions aimed at harnessing the immunoregula-
tory potential of NKT cells.
MATERIALS AND METHODS
Purification and preparation of primary human T
cell subsets and DCs
PBMC were isolated from either neonatal cord blood or
peripheral adult blood from healthy individuals by Ficoll
(Pharmacia) density centrifugation. NKT cells were enriched from
adult PBMC or neonatal CD4+ T cells by staining with Va24
antibody, followed by goat anti-mouse magnetic beads (Miltenyi
Biotec), and positively sorted by magnetic cell sorting using
AutoMACS (Miltenyi Biotec) as described [30]. CD4+ conven-
tional T cells (Th cells) were purified from PBMC using Dynabead
anti-CD4 antibodies and magnetic separation, as previously
described [44]. Monocyte-derived DCs were prepared as pre-
viously described [69,70]. DCs were matured by stimulation with
10 ng/ml LPS (Sigma) one day prior to T cell activation. All
subjects provided written informed consent that was approved by
the Vanderbilt Institutional Review Board.
T cell activation and differentiation
Purified Va24+ NKT cells were stimulated with a-GalCer
(100 ng/mL, Kirin Brewery Co., Gunma, Japan) using mature
DCs. CD4+ Th cells were activated by DCs using Staphylococcus
enterotoxin B (SEB, 20 ng/mL, Sigma). For cytokine polarization,
cells were activated in the presence or absence of polarizing
cytokine conditions as previously described for conventional CD4+
Th cells [44] under the following conditions: human rhIL-12
(30 ng/ml) and neutralizing anti-IL-4 antibody (0.5 mg/mL) for
Th1 conditions and human rhIL-4 (50 ng/mL) and neutralizing
anti-IFN-c (2.5 mg/ml) and anti-IL-12 (2.5 mg/ml) antibodies for
Th2 conditions (all from R&D Systems) [44]. Cells were expanded
in rhIL-2 containing media. The culture media used in all
experiments was as described [70]. For purification of aCD4+ or
aCD42 NKT cells, from expanded adult NKT cell lines, cells
were stained with Vb11 (Immunotech) to exclude any contami-
nating non-NKT cells and CD4 (BD Pharmingen); aCD4+ and
aCD42 NKT cells were sorted using flow cytometry (FACS Aria,
BD Pharmingen).
Virus production and infections
Vesicular stomatitis virus glycoprotein (VSV-G)-pseudotyped
lentiviruses were generated as previously described [70]. Briefly,
HEK-293T cells were transfected with lentiviral vectors and VSV-
G envelope plasmids. Supernatants were collected 48 h post-
transfection and filtered through 0.45 mM filters. Construction
and use of lentiviral vectors expressing a marker gene (murine
CD24, mCD24) and either GATA-3 or T-bet have also been
described [44,70]. For transduction experiments, NKT and
conventional CD4+ Th cells were infected at the time of activation
at a multiplicity of infection of 3–8.
Staining and FACS analysis
Cells were stained with the relevant antibody and analyzed using
a flow cytometer (FACSCalibur) as described [44]. Analysis was
performed using FlowJo software (Tree Star). The following anti-
human antibodies were used for staining: Va24, Vb11 (Immuno-
tech); CD4, CD8, CD28, CD94, CD161, CD25, CCR4, CXCR3,
CD62L (all from BD Pharmingen) and CCR7 (R&D Systems). In
some experiments mCD24 antibody (BD Pharmingen) was used as
marker for lentivirus-transduced T cells. Secondary goat anti-
mouse antibody and streptavidin conjugates were from BD
Pharmingen and pure mouse IgG1 was purchased from Caltag.
Cytokine expression assays
For intracellular cytokine analysis, NKT and CD4+ Th cells were
stimulated with a2GalCer (100 ng/ml) or SEB (20 ng/ml) pulsed
DCs, respectively, or alternatively by cross-linking the TCR with
antibodies against CD3 (OKT3, American Type Culture
Collection (ATCC)) and CD28 (BD Biosciences), in the presence
of 0.67 ml/ml GolgiStop (BD Pharmingen) and incubated for 6–
8 hours at 37uC. This was followed by cell surface staining for
CD4 to identify cells from either the CD4+ or CD42 lineage and
anti-Vb11 to exclude any contaminating non-NKT cells. Lenti-
viral transduction was monitored using anti-mCD24. Subsequent-
ly, cells were fixed and permeabilized using a commercial kit (BD
Pharmingen) according to the manufacturer’s instructions. Cells
were then stained with the following anti-human cytokine
antibodies: IFN-c and IL-4 (both from BD Pharmingen).
Cytotoxicity Assay
Murine fibroblast cells (NIH-3T3) expressing endogenous murine
CD1d were seeded in a 96 well plate at 8,000 cells per well and
incubated for 1–3 h to adhere. To activate NKT cells, a-GalCer
(between 0.01–100 ng/ml) was added to these cultures. For CD4+
Th cell activations, 3T3 cells ectopically expressing the human
class II molecule HLA-DR were pulsed with SEB (20 ng/mL).
Effector cells (NKT or Th) were then added at various effector
to target ratios (2:1 to 1:32). After 18–20 hours, cells were
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10 mg/ml, Sigma) or anti-CD25 and analyzed by flow cytometry.
For experiments comparing different NKT or Th lines, a negative
control was used for normalization between samples. 3T3 cells
were distinguished from NKT or CD4+ Th cells by their
distinctive larger forward and side scatter profiles.
Statistical Analysis
Statistical analyses were performed using STATA version 9.0. In
all cases, a p-value,0.05 was considered statistically significant.
Due to the non-normal nature of the distributions, non-parametric
tests were used for all comparisons in order to avoid spurious
results. Linear regression was used to characterize the relationship
between CCR7 expression and the ratio of CD161:CD62L
expression in aCD4+ NKT cells. A Kruskal-Wallis test was used
for the initial comparisons of the distribution of cell surface marker
expression profiles of nCD4+, aCD4+, and aCD42 NKT cell
subsets, followed by pair-wise comparison tests. For non-matched
comparisons, the Wilcoxon rank-sum test was used, and for
matched comparisons, the Wilcoxon’s signed rank test was
performed. It is important to note that the p-values presented
are uncorrected for the multiple tests performed in the pair-wise
comparisons, yet even with a highly conservative Bonferroni
correction, all results except one are still statistically significant.
SUPPORTING INFORMATION
Figure S1 Cytokine polarization of CB CD4+ Th cells.
CB CD4+ T helper cells were activated under Th0- Th1- or
Th2-polarizing conditions as described in the methods and
expanded in IL-2-containing media. These cells were re-
stimulated using DCs pulsed with SEB (20 ng/ml) or anti-CD3
and anti-CD28 in the presence of GolgiStop (6-8 hrs) and
subsequently stained intracellularly with anti-IL-4 (PE) and anti-
IFN-c (APC).
Found at: doi:10.1371/journal.pone.0000050.s001 (0.08 MB TIF)
Figure S2 Cytotoxic capacity of polarized neonatal Th cells.
Polarized Th1 or Th2 neonatal lines were generated as in Figure
S1. The cytotoxic capacity upon activation at different Th:3T3
ratios of these lines was assayed as in Figure 5B using 20ng/ml
SEB for each. Experiments were performed in triplicate per donor;
standard deviation is depicted. One representative donor out of
three is shown.
Found at: doi:10.1371/journal.pone.0000050.s002 (0.08 MB TIF)
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